The Latin America, Middle East and Africa Cellular Health Screening Market would witness market growth of 10.5% CAGR during the forecast period (2022-2028).
Screening kits can be utilized to assess inflammatory diseases such as allergies, respiratory issues, reactive arthritis, joint pain, and inflammatory intestinal issues. Additionally, it can be used to monitor how effectively a patient adapts to treatments. The prevalence of chronic diseases and an increase in healthcare awareness are the prominent drivers influencing the acceptance of cellular health screening.
The growing geriatric population and consequent growth in the requirement for cellular health screening, growing adoption of the directly-to-consumer approach, rising government emphasis on preventive healthcare, increasing telomere performance programs for leading a healthy life, and the growing onus of chronic conditions are together pushing for improved diagnostic methods such as the cellular health screening techniques. Precision medicine or personalized medicine is expected to become more significant, and it will also become more necessary to examine cellular health and aging biomarkers in general.
The use of personal diagnostic tests is steadily increasing. Growth is anticipated to be fueled by the increasing number of public awareness programs aimed at teaching people about the symptoms of chronic illnesses and how to manage them in an effort to stop disease epidemics. Due to increased patient awareness, there is a substantial need for cellular health screening test kits and services. Additionally, the adoption of these tools improves timely treatment choices, boosts the efficacy of care provided, and significantly reduces diagnosis costs, particularly in resource-constrained nations with subpar laboratory facilities.
In the Latin America region's low- and middle-income nations compared to high-income countries, NCD (Non-Communicable Disease)-related fatalities happen sooner in life. In Latin America, men are more likely than women to die prematurely from NCDs. Those who have NCDs must endure years of infirmity, which is bad for their dependents and the nation's economy. Smoking is a significant contributor to the risk of several malignancies, chronic respiratory conditions, and cardiovascular disease, and it is unquestionably more common in the region's big cities. More than half of adolescents already reside in urban areas in the region world in general, which has increased the occurrence of smoking even more among them.
The Brazil market dominated the LAMEA Cellular Health Screening Market by Country in 2021; thereby, achieving a market value of $63.8 million by 2028. The Argentina market would experience a CAGR of 11.1% during (2022 - 2028). Additionally, The UAE market is poised to grow a CAGR of 10.2% during (2022 - 2028).
Based on Sample Type, the market is segmented into Blood, Saliva, Serum, and Urine. Based on Collection Site, the market is segmented into Hospital, Diagnostic Labs, Home, and Office. Based on Test Type, the market is segmented into Single Test Panels and Multi-test Panels. Based on Single Test Panels Type, the market is segmented into Oxidative Stress Tests, Inflammation Tests, Telomere Tests, and Heavy Metals Tests. The report also covers geographical segmentation of Cellular Health Screening market. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
Free Valuable Insights: The Global Cellular Health Screening Market is Predict to reach $4.3 Billion by 2028, at a CAGR of 9%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Quest Diagnostics Incorporated, OPKO Health, Inc., Laboratory Corporation of America Holdings, Genova Diagnostics, Telomere Diagnostics, Inc., Life Length, S.L., Repeat Diagnostics, Inc., SpectraCell Laboratories, Inc. (Beingmate Group Co. Ltd.), Cell Science Systems Corp. and Segterra, Inc.
Scope of the Study
Market Segments Covered in the Report:
By Sample Type
By Collection Site
- Hospital
- Diagnostic Labs
- Home
- Office
By Test Type
- Single Test Panels
- Oxidative Stress Tests
- Inflammation Tests
- Telomere Tests
- Heavy Metals Tests
- Multi-test Panels
By Country
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA
Key Market Players
List of Companies Profiled in the Report:
Companies Profiled
- Quest Diagnostics Incorporated
- OPKO Health, Inc.
- Laboratory Corporation of America Holdings
- Genova Diagnostics
- Telomere Diagnostics, Inc.
- Life Length, S.L.
- Repeat Diagnostics, Inc.
- SpectraCell Laboratories, Inc. (Beingmate Group Co. Ltd.)
- Cell Science Systems Corp.
- Segterra, Inc.
TABLE 1 LAMEA Cellular Health Screening Market, 2018 - 2021, USD Million
TABLE 2 LAMEA Cellular Health Screening Market, 2022 - 2028, USD Million
TABLE 3 LAMEA Cellular Health Screening Market by Sample Type, 2018 - 2021, USD Million
TABLE 4 LAMEA Cellular Health Screening Market by Sample Type, 2022 - 2028, USD Million
TABLE 5 LAMEA Blood Market by Country, 2018 - 2021, USD Million
TABLE 6 LAMEA Blood Market by Country, 2022 - 2028, USD Million
TABLE 7 LAMEA Saliva Market by Country, 2018 - 2021, USD Million
TABLE 8 LAMEA Saliva Market by Country, 2022 - 2028, USD Million
TABLE 9 LAMEA Serum Market by Country, 2018 - 2021, USD Million
TABLE 10 LAMEA Serum Market by Country, 2022 - 2028, USD Million
TABLE 11 LAMEA Urine Market by Country, 2018 - 2021, USD Million
TABLE 12 LAMEA Urine Market by Country, 2022 - 2028, USD Million
TABLE 13 LAMEA Cellular Health Screening Market by Collection Site, 2018 - 2021, USD Million
TABLE 14 LAMEA Cellular Health Screening Market by Collection Site, 2022 - 2028, USD Million
TABLE 15 LAMEA Hospital Market by Country, 2018 - 2021, USD Million
TABLE 16 LAMEA Hospital Market by Country, 2022 - 2028, USD Million
TABLE 17 LAMEA Diagnostic Labs Market by Country, 2018 - 2021, USD Million
TABLE 18 LAMEA Diagnostic Labs Market by Country, 2022 - 2028, USD Million
TABLE 19 LAMEA Home Market by Country, 2018 - 2021, USD Million
TABLE 20 LAMEA Home Market by Country, 2022 - 2028, USD Million
TABLE 21 LAMEA Office Market by Country, 2018 - 2021, USD Million
TABLE 22 LAMEA Office Market by Country, 2022 - 2028, USD Million
TABLE 23 LAMEA Cellular Health Screening Market by Test Type, 2018 - 2021, USD Million
TABLE 24 LAMEA Cellular Health Screening Market by Test Type, 2022 - 2028, USD Million
TABLE 25 LAMEA Single Test Panels Market by Country, 2018 - 2021, USD Million
TABLE 26 LAMEA Single Test Panels Market by Country, 2022 - 2028, USD Million
TABLE 27 LAMEA Cellular Health Screening Market by Single Test Panels Type, 2018 - 2021, USD Million
TABLE 28 LAMEA Cellular Health Screening Market by Single Test Panels Type, 2022 - 2028, USD Million
TABLE 29 LAMEA Oxidative Stress Tests Market by Country, 2018 - 2021, USD Million
TABLE 30 LAMEA Oxidative Stress Tests Market by Country, 2022 - 2028, USD Million
TABLE 31 LAMEA Inflammation Tests Market by Country, 2018 - 2021, USD Million
TABLE 32 LAMEA Inflammation Tests Market by Country, 2022 - 2028, USD Million
TABLE 33 LAMEA Telomere Tests Market by Country, 2018 - 2021, USD Million
TABLE 34 LAMEA Telomere Tests Market by Country, 2022 - 2028, USD Million
TABLE 35 LAMEA Heavy Metals Tests Market by Country, 2018 - 2021, USD Million
TABLE 36 LAMEA Heavy Metals Tests Market by Country, 2022 - 2028, USD Million
TABLE 37 LAMEA Multi-test Panels Market by Country, 2018 - 2021, USD Million
TABLE 38 LAMEA Multi-test Panels Market by Country, 2022 - 2028, USD Million
TABLE 39 LAMEA Cellular Health Screening Market by Country, 2018 - 2021, USD Million
TABLE 40 LAMEA Cellular Health Screening Market by Country, 2022 - 2028, USD Million
TABLE 41 Brazil Cellular Health Screening Market, 2018 - 2021, USD Million
TABLE 42 Brazil Cellular Health Screening Market, 2022 - 2028, USD Million
TABLE 43 Brazil Cellular Health Screening Market by Sample Type, 2018 - 2021, USD Million
TABLE 44 Brazil Cellular Health Screening Market by Sample Type, 2022 - 2028, USD Million
TABLE 45 Brazil Cellular Health Screening Market by Collection Site, 2018 - 2021, USD Million
TABLE 46 Brazil Cellular Health Screening Market by Collection Site, 2022 - 2028, USD Million
TABLE 47 Brazil Cellular Health Screening Market by Test Type, 2018 - 2021, USD Million
TABLE 48 Brazil Cellular Health Screening Market by Test Type, 2022 - 2028, USD Million
TABLE 49 Brazil Cellular Health Screening Market by Single Test Panels Type, 2018 - 2021, USD Million
TABLE 50 Brazil Cellular Health Screening Market by Single Test Panels Type, 2022 - 2028, USD Million
TABLE 51 Argentina Cellular Health Screening Market, 2018 - 2021, USD Million
TABLE 52 Argentina Cellular Health Screening Market, 2022 - 2028, USD Million
TABLE 53 Argentina Cellular Health Screening Market by Sample Type, 2018 - 2021, USD Million
TABLE 54 Argentina Cellular Health Screening Market by Sample Type, 2022 - 2028, USD Million
TABLE 55 Argentina Cellular Health Screening Market by Collection Site, 2018 - 2021, USD Million
TABLE 56 Argentina Cellular Health Screening Market by Collection Site, 2022 - 2028, USD Million
TABLE 57 Argentina Cellular Health Screening Market by Test Type, 2018 - 2021, USD Million
TABLE 58 Argentina Cellular Health Screening Market by Test Type, 2022 - 2028, USD Million
TABLE 59 Argentina Cellular Health Screening Market by Single Test Panels Type, 2018 - 2021, USD Million
TABLE 60 Argentina Cellular Health Screening Market by Single Test Panels Type, 2022 - 2028, USD Million
TABLE 61 UAE Cellular Health Screening Market, 2018 - 2021, USD Million
TABLE 62 UAE Cellular Health Screening Market, 2022 - 2028, USD Million
TABLE 63 UAE Cellular Health Screening Market by Sample Type, 2018 - 2021, USD Million
TABLE 64 UAE Cellular Health Screening Market by Sample Type, 2022 - 2028, USD Million
TABLE 65 UAE Cellular Health Screening Market by Collection Site, 2018 - 2021, USD Million
TABLE 66 UAE Cellular Health Screening Market by Collection Site, 2022 - 2028, USD Million
TABLE 67 UAE Cellular Health Screening Market by Test Type, 2018 - 2021, USD Million
TABLE 68 UAE Cellular Health Screening Market by Test Type, 2022 - 2028, USD Million
TABLE 69 UAE Cellular Health Screening Market by Single Test Panels Type, 2018 - 2021, USD Million
TABLE 70 UAE Cellular Health Screening Market by Single Test Panels Type, 2022 - 2028, USD Million
TABLE 71 Saudi Arabia Cellular Health Screening Market, 2018 - 2021, USD Million
TABLE 72 Saudi Arabia Cellular Health Screening Market, 2022 - 2028, USD Million
TABLE 73 Saudi Arabia Cellular Health Screening Market by Sample Type, 2018 - 2021, USD Million
TABLE 74 Saudi Arabia Cellular Health Screening Market by Sample Type, 2022 - 2028, USD Million
TABLE 75 Saudi Arabia Cellular Health Screening Market by Collection Site, 2018 - 2021, USD Million
TABLE 76 Saudi Arabia Cellular Health Screening Market by Collection Site, 2022 - 2028, USD Million
TABLE 77 Saudi Arabia Cellular Health Screening Market by Test Type, 2018 - 2021, USD Million
TABLE 78 Saudi Arabia Cellular Health Screening Market by Test Type, 2022 - 2028, USD Million
TABLE 79 Saudi Arabia Cellular Health Screening Market by Single Test Panels Type, 2018 - 2021, USD Million
TABLE 80 Saudi Arabia Cellular Health Screening Market by Single Test Panels Type, 2022 - 2028, USD Million
TABLE 81 South Africa Cellular Health Screening Market, 2018 - 2021, USD Million
TABLE 82 South Africa Cellular Health Screening Market, 2022 - 2028, USD Million
TABLE 83 South Africa Cellular Health Screening Market by Sample Type, 2018 - 2021, USD Million
TABLE 84 South Africa Cellular Health Screening Market by Sample Type, 2022 - 2028, USD Million
TABLE 85 South Africa Cellular Health Screening Market by Collection Site, 2018 - 2021, USD Million
TABLE 86 South Africa Cellular Health Screening Market by Collection Site, 2022 - 2028, USD Million
TABLE 87 South Africa Cellular Health Screening Market by Test Type, 2018 - 2021, USD Million
TABLE 88 South Africa Cellular Health Screening Market by Test Type, 2022 - 2028, USD Million
TABLE 89 South Africa Cellular Health Screening Market by Single Test Panels Type, 2018 - 2021, USD Million
TABLE 90 South Africa Cellular Health Screening Market by Single Test Panels Type, 2022 - 2028, USD Million
TABLE 91 Nigeria Cellular Health Screening Market, 2018 - 2021, USD Million
TABLE 92 Nigeria Cellular Health Screening Market, 2022 - 2028, USD Million
TABLE 93 Nigeria Cellular Health Screening Market by Sample Type, 2018 - 2021, USD Million
TABLE 94 Nigeria Cellular Health Screening Market by Sample Type, 2022 - 2028, USD Million
TABLE 95 Nigeria Cellular Health Screening Market by Collection Site, 2018 - 2021, USD Million
TABLE 96 Nigeria Cellular Health Screening Market by Collection Site, 2022 - 2028, USD Million
TABLE 97 Nigeria Cellular Health Screening Market by Test Type, 2018 - 2021, USD Million
TABLE 98 Nigeria Cellular Health Screening Market by Test Type, 2022 - 2028, USD Million
TABLE 99 Nigeria Cellular Health Screening Market by Single Test Panels Type, 2018 - 2021, USD Million
TABLE 100 Nigeria Cellular Health Screening Market by Single Test Panels Type, 2022 - 2028, USD Million
TABLE 101 Rest of LAMEA Cellular Health Screening Market, 2018 - 2021, USD Million
TABLE 102 Rest of LAMEA Cellular Health Screening Market, 2022 - 2028, USD Million
TABLE 103 Rest of LAMEA Cellular Health Screening Market by Sample Type, 2018 - 2021, USD Million
TABLE 104 Rest of LAMEA Cellular Health Screening Market by Sample Type, 2022 - 2028, USD Million
TABLE 105 Rest of LAMEA Cellular Health Screening Market by Collection Site, 2018 - 2021, USD Million
TABLE 106 Rest of LAMEA Cellular Health Screening Market by Collection Site, 2022 - 2028, USD Million
TABLE 107 Rest of LAMEA Cellular Health Screening Market by Test Type, 2018 - 2021, USD Million
TABLE 108 Rest of LAMEA Cellular Health Screening Market by Test Type, 2022 - 2028, USD Million
TABLE 109 Rest of LAMEA Cellular Health Screening Market by Single Test Panels Type, 2018 - 2021, USD Million
TABLE 110 Rest of LAMEA Cellular Health Screening Market by Single Test Panels Type, 2022 - 2028, USD Million
TABLE 111 Key information – Quest Diagnostics Incorporated
TABLE 112 Key Information – OPKO Health, Inc.
TABLE 113 Key Information – Laboratory Corporation of America holdings
TABLE 114 Key Information – Genova Diagnostics
TABLE 115 Key Information – Telomere Diagnostics, Inc.
TABLE 116 Key Information – LIFE LENGTH, S.L.
TABLE 117 Key Information – Repeat Diagnostics, Inc.
TABLE 118 Key Information – SpectraCell Laboratories, Inc.
TABLE 119 Key Information – Cell Science Systems Corp.
TABLE 120 Key Information – SEGTERRA (INSIDETRACKER)
List of Figures
FIG 1 Methodology for the research
FIG 2 Recent strategies and developments: Quest Diagnostics Incorporated